A detailed history of Mercer Global Advisors Inc transactions in Medpace Holdings, Inc. stock. As of the latest transaction made, Mercer Global Advisors Inc holds 11,131 shares of MEDP stock, worth $3.76 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
11,131
Previous 11,666 4.59%
Holding current value
$3.76 Million
Previous $4.8 Million 22.73%
% of portfolio
0.01%
Previous 0.01%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$320.58 - $457.29 $171,510 - $244,650
-535 Reduced 4.59%
11,131 $3.71 Million
Q2 2024

Aug 12, 2024

BUY
$372.0 - $424.34 $353,028 - $402,698
949 Added 8.86%
11,666 $4.8 Million
Q1 2024

May 15, 2024

BUY
$284.87 - $413.31 $2.09 Million - $3.03 Million
7,329 Added 216.32%
10,717 $4.33 Million
Q4 2023

Feb 14, 2024

BUY
$227.52 - $312.68 $38,678 - $53,155
170 Added 5.28%
3,388 $1.04 Million
Q3 2023

Nov 13, 2023

BUY
$233.98 - $281.67 $375,537 - $452,080
1,605 Added 99.5%
3,218 $779,000
Q2 2023

Aug 14, 2023

BUY
$187.26 - $240.17 $23,594 - $30,261
126 Added 8.47%
1,613 $387,000
Q1 2023

May 15, 2023

SELL
$174.31 - $239.52 $29,109 - $39,999
-167 Reduced 10.1%
1,487 $279,000
Q4 2022

Feb 08, 2023

SELL
$153.06 - $226.57 $39,336 - $58,228
-257 Reduced 13.45%
1,654 $351,000
Q3 2022

Nov 15, 2022

SELL
$145.13 - $182.49 $2,612 - $3,284
-18 Reduced 0.93%
1,911 $300,000
Q2 2022

Aug 10, 2022

BUY
$130.2 - $168.03 $86,192 - $111,235
662 Added 52.25%
1,929 $289,000
Q1 2022

May 10, 2022

BUY
$138.87 - $214.31 $175,948 - $271,530
1,267 New
1,267 $207,000

Others Institutions Holding MEDP

About Medpace Holdings, Inc.


  • Ticker MEDP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 31,099,900
  • Market Cap $10.5B
  • Description
  • Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, bi...
More about MEDP
Track This Portfolio

Track Mercer Global Advisors Inc Portfolio

Follow Mercer Global Advisors Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mercer Global Advisors Inc , based on Form 13F filings with the SEC.

News

Stay updated on Mercer Global Advisors Inc with notifications on news.